• What best describes your title?*
  • 1. Which of the following is not correct about the 2025 EAS/ESC Dyslipidemia Guideline update?*
  • 2. Which of the following is correct about olezarsen?*
  • 3. Oral versions of PCSK9 inhibition in clinical trials have achieved how much LDL reduction?*
  • 4. Which of the following LDL-lowering drugs is an siRNA?*
  • How many patients do you currently see each month with dyslipidemia?
  • Learning Objectives
    Rows
  • Please provide us with feedback regarding your experience at the activity:
    Rows
  • Do you feel this activity was fair, balanced, and free of commercial bias?
  • This educational activity will result in a change in my role as a healthcare team member.
  • Based on your participation in this activity, choose the statement(s) that applies to how your role as a healthcare team member will change:

  • Attestation:

    AcademicCME designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditsTM.

    Participants should claim only the credit commensurate with the extent of their participation in the activity.

  • Date
     - -
    2 digit month, 2 digit day, 4 digit year
  • Should be Empty: